Skip to main content

Sutent Alternatives Compared

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Sutent (sunitinib) Votrient (pazopanib) Inlyta (axitinib)
View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Sutent (sunitinib) Votrient (pazopanib) Inlyta (axitinib)
Prescription only

Sutent is an oral capsule that may be taken once daily to treat certain types of RCC and other advanced cancers. It may be taken every day or for 4 weeks on, 2 weeks off schedule. It has been... View more

Prescription only

Prescribed for Soft Tissue Sarcoma, Renal Cell Carcinoma. Votrient may also be used for purposes not listed in this medication guide.

Prescription only

Prescribed for Renal Cell Carcinoma. Inlyta may also be used for purposes not listed in this medication guide.

Related suggestions
More about Sutent (sunitinib) More about Votrient (pazopanib) More about Inlyta (axitinib)
Ratings & Reviews

Sutent has an average rating of 7.6 out of 10 from a total of 30 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 17% reported a negative effect.

Votrient has an average rating of 8.0 out of 10 from a total of 82 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 9% reported a negative effect.

Inlyta has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect.

View all 30 reviews

View all 82 reviews

View all 1 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

View all Sutent side effects

View all Votrient side effects

View all Inlyta side effects
Drug Class
Generic Availability

Lower cost generic approved

Lower cost generic approved

No lower cost generic approved
Pricing and Coupons * Prices are without insurance
Quantity 28 capsule
Strength 12.5 mg
Per unit* $246.51
Cost* $6,902.35

View all Sutent prices

Quantity 120 tablet
Strength 200 mg
Per unit* $158.60
Cost* $19,031.77

View all Votrient prices

Quantity 180 tablet
Strength 1 mg
Per unit* $125.56
Cost* $22,600.86

View all Inlyta prices

Get free Discount Card

Get free Discount Card

Get free Discount Card

Dosage Forms
  • Oral capsule
  • Oral tablet
  • Oral tablet
Brand Names

N/A

N/A

N/A
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

60 hours

30.9 hours

6.1 hours
CSA Schedule 1 View glossary of CSA terms
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
Pregnancy Category
D
Category D Positive evidence of risk

See the full pregnancy warnings document.
D
Category D Positive evidence of risk

See the full pregnancy warnings document.
D
Category D Positive evidence of risk

See the full pregnancy warnings document.
Drug Interactions

A total of 485 drugs are known to interact with Sutent:

  • 93 major drug interactions (250 brand and generic names)
  • 391 moderate drug interactions (1340 brand and generic names)
  • 1 minor drug interactions (2 brand and generic names)

A total of 697 drugs are known to interact with Votrient:

  • 170 major drug interactions (578 brand and generic names)
  • 511 moderate drug interactions (1702 brand and generic names)
  • 16 minor drug interactions (36 brand and generic names)

A total of 248 drugs are known to interact with Inlyta:

  • 62 major drug interactions (199 brand and generic names)
  • 164 moderate drug interactions (446 brand and generic names)
  • 22 minor drug interactions (183 brand and generic names)
Alcohol/Food/Lifestyle Interactions
  • SUNItinib may be taken with or without food. If you are receiving therapy with SUNItinib you... View more
  • Do not consume grapefruit or grapefruit juice during treatment with PAZOPanib unless directed... View more
  • Do not consume grapefruit or grapefruit juice during treatment with axitinib unless directed... View more
Disease Interactions
First Approval Date

January 26, 2006

October 19, 2009

January 27, 2012
WADA Class View classifications

N/A

N/A

N/A
More Information
Patient Resources
Professional Resources
Related Treatment Guide

1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Compare Drugs

To view a report comparing 3 (or more) medications, please sign in or create an account.

Create an account Sign In